SAN DIEGO — Visual field defect on baseline 10-2 testing most effectively predicted subsequent progression on 24-2 testing in patients with glaucoma, Michael J. Sullivan-Mee, OD, FAAO, said at an ...

Please provide your email address to receive an email when new articles are posted on . Patients with genetic risk for different glaucoma subtypes had an associated risk for different visual field ...

A common eye ointment may quietly damage glaucoma implants—sometimes to the point of rupture—by making them swell from the ...

Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or attention deficits. The study involved glaucoma patients and healthy controls, ...

Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with glaucoma, according to a retrospective cohort study. Among 985 patients, the ...

As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...

Glaucoma affects peripheral vision, creating blind spots in the outer edges of a person’s visual field. This can affect daily activities such as driving and walking. Glaucoma is the name for a group ...

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase by 58% to more than 4.2 million people. Glaucoma is an eye disease ...

The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.